Results for pharmacodynamics translation from French to English

the influence of lipids on the pharmacokinetics and pharmacodynamics of some representative highly lipophilic, cytochrome p-450 3a substrates
regulation of synthesis of nitric oxide (no) and its effects: a pivot point in control of mast cell phenotype and function

points to consider on pharmaco-kinetics and pharmacodynamics in the development of anti-bacterial medicinal products adoptée en juillet 2000
treatment of mucopolysaccharidosis type i

note for guidance on clinical investigation of medical products in the treatment of obsessive-compulsive disorder addendum on acute cardiac failure to the cpmp note for guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia note for guidance on clinical investigation of steroid contraceptives in women revision of note for guidance on evaluation of new anti-bacterial medicinal products (cpmp/ewp/558/95) and note for guidance on the pharmacodynamic section of the summary of product characteristics for antibacterial medicinal products
cpmp safety working party document title position paper on the non-clinical safety studies to support clinical trials with a single low dose of a compound note for guidance on specification limits for residues of metal catalysts note for guidance on comparability of medicinal products containing biotechnology-derived proteins as drug substance:annex on non-clinical and clinical considerations